Apr 5, 2023· Comment from Association for Accessible Medicines (AAM)· FDA-2023-N-0254-0007
FDA, Please find attached the Biosimilars Council's comments on FDA Docket No. FDA-2023-N-0254, "BsUFA III Regulatory Research Pilot Program: RESEARCH ROADMAP." Thanks, Scott Kuzner, Ph.D. Senior Director, Sciences and Regulatory Affairs Association for Accessible Medicines (AAM)